tirzepatide dosage maintenance therapy on semaglutide or Staying on a Tirzepatide Maintenance
Description
The average weight loss at this point is around 22 to 26% of starting body weight, though individual results vary
Patients planning to discontinue GLP-1 therapy
Common side effects may include nausea or fatigue during the first few doses, but these usually subside as your body adjusts
In addition to tracking your weight, these sessions provide an opportunity to evaluate other important aspects of your progress
If you or someone close to you were diagnosed with stomach paralysis, bowel obstruction, or vision loss after taking tirzepatide, contact us
That combination of a powerful medication and an uncontrolled product is where real harm happens
